Intra-Articular Injection
-
Biologics
Samumed Phase 2b Trial in Knee Osteoarthritis Meets Primary Endpoints
SAN DIEGO, Oct. 24, 2018 (GLOBE NEWSWIRE) — Samumed announced today top-line data from its phase 2b trial of SM04690…
Read More » -
Biologics
Bone Therapeutics announces single intra-articular injection of viscosupplement JTA-004 delivered higher pain reduction than the reference in first study in knee osteoarthritis
Gosselies, Belgium, 17 October 2018, 6 pm CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company…
Read More »